(Q38170863)

30 June 2019

title

A historical and practical review of first trimester aneuploidy screening (English)

1 reference

30 June 2019

author name string

Melissa L Russo

series ordinal

1

1 reference

30 June 2019

Karin J Blakemore

series ordinal

2

1 reference

30 June 2019

publication date

14 December 2013

1 reference

30 June 2019

Seminars in Fetal and Neonatal Medicine

published in

1 reference

30 June 2019

volume

19

1 reference

30 June 2019

issue

3

1 reference

30 June 2019

page(s)

183-187

1 reference

30 June 2019

A screening program for trisomy 21 at 10-14 weeks using fetal nuchal translucency, maternal serum free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A

cites work

1 reference

12 December 2020

Integrated screening for Down's syndrome based on tests performed during the first and second trimesters

1 reference

12 December 2020

First-trimester Down syndrome screening using dried blood biochemistry and nuchal translucency

1 reference

12 December 2020

Fetal gender and aneuploidy detection using fetal cells in maternal blood: analysis of NIFTY I data. National Institute of Child Health and Development Fetal Cell Isolation Study.

1 reference

12 December 2020

Integrated ultrasound and biochemical screening for trisomy 21 using fetal nuchal translucency, absent fetal nasal bone, free beta-hCG and PAPP-A at 11 to 14 weeks

1 reference

12 December 2020

[Demonstration of fetal hemoglobin in erythrocytes of a blood smear]

1 reference

12 December 2020

Free beta-hCG as first-trimester marker for fetal trisomy

1 reference

12 December 2020

First trimester concentrations of pregnancy associated plasma protein A and placental protein 14 in Down's syndrome

1 reference

12 December 2020

Fetal nuchal translucency: ultrasound screening for chromosomal defects in first trimester of pregnancy

1 reference

12 December 2020

First-trimester screening for trisomies 21 and 18

1 reference

12 December 2020

1 reference

12 December 2020

Second-trimester maternal serum immunoreactive inhibin as a marker for fetal Down's syndrome

1 reference

12 December 2020

First-trimester or second-trimester screening, or both, for Down's syndrome

1 reference

12 December 2020

Maternal serum Down syndrome screening: Free β-protein is a more effective marker than human chorionic gonadotropin

1 reference

12 December 2020

Prenatal diagnosis with fetal cells isolated from maternal blood by multiparameter flow cytometry

1 reference

12 December 2020

Noninvasive diagnosis of fetal aneuploidy by shotgun sequencing DNA from maternal blood

1 reference

12 December 2020

Noninvasive prenatal diagnosis of fetal chromosomal aneuploidy by massively parallel genomic sequencing of DNA in maternal plasma

1 reference

12 December 2020

Amniocentesis and chorionic villus sampling

1 reference

12 December 2020

Non-invasive prenatal assessment of trisomy 21 by multiplexed maternal plasma DNA sequencing: large scale validity study

1 reference

12 December 2020

DNA sequencing of maternal plasma to detect Down syndrome: an international clinical validation study

1 reference

12 December 2020

DNA sequencing of maternal plasma reliably identifies trisomy 18 and trisomy 13 as well as Down syndrome: an international collaborative study

1 reference

12 December 2020

Genome-wide fetal aneuploidy detection by maternal plasma DNA sequencing

1 reference

12 December 2020

Non-Invasive Chromosomal Evaluation (NICE) Study: results of a multicenter prospective cohort study for detection of fetal trisomy 21 and trisomy 18.

1 reference

12 December 2020

Abnormal maternal serum chorionic gonadotropin levels in pregnancies with fetal chromosome abnormalities

1 reference

12 December 2020

Maternal serum screening for Down's syndrome in early pregnancy

1 reference

12 December 2020

Fetal cells in the blood of pregnant women: detection and enrichment by fluorescence-activated cell sorting

1 reference

12 December 2020

Low second trimester maternal serum unconjugated oestriol in pregnancies with Down's syndrome

1 reference

12 December 2020

An association between low maternal serum α-fetoprotein and fetal chromosomal abnormalities

1 reference

12 December 2020

Maternal serum alpha-fetoprotein measurement: a screening test for Down syndrome

1 reference

12 December 2020

Detection and isolation of fetal cells from maternal blood using the flourescence-activated cell sorter (FACS)

1 reference

12 December 2020

Serum PAPP-A and free beta-hCG are first-trimester screening markers for Down syndrome

1 reference

12 December 2020

First‐trimester free beta (hCG) screening for Down syndrome

1 reference

12 December 2020

Serum PAPP‐A levels are depressed in women with fetal Down syndrome in early pregnancy

1 reference

12 December 2020

Chromosomal defects and outcome in 1015 fetuses with increased nuchal translucency

1 reference

12 December 2020

First-trimester Down's syndrome screening using nuchal translucency: a prospective study in patients undergoing chorionic villus sampling

1 reference

12 December 2020

Screening for fetal trisomies by maternal age and fetal nuchal translucency thickness at 10 to 14 weeks of gestation

1 reference

12 December 2020

Screening for fetal trisomy 21 in the first trimester of pregnancy: maternal serum free beta-hCG and fetal nuchal translucency thickness

1 reference

12 December 2020

Presence of fetal DNA in maternal plasma and serum

1 reference

12 December 2020

Combining ultrasound and biochemistry in first-trimester screening for Down's syndrome.

1 reference

12 December 2020

Screening for Down's syndrome: the effect of test date on the detection rate.

1 reference

12 December 2020

First-trimester screening for fetal aneuploidy: biochemistry and nuchal translucency

1 reference

12 December 2020

UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal-translucency thickness at 10–14 weeks of gestation

1 reference

12 December 2020

The effect of fetal neck position on nuchal translucency measurement

1 reference

12 December 2020

Second trimester screening for Down's syndrome using maternal serum dimeric inhibin A.

1 reference

12 December 2020

10.1016/J.SINY.2013.11.013

Identifiers

DOI

1 reference

30 June 2019

PMC publication ID

6596981

1 reference

30 June 2019

PubMed publication ID

24333205

1 reference

30 June 2019